Clinical Trial Update: 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

View source ↗

Summary

Clinical trial update notes an expanded access protocol for 131I-MIBG therapy in refractory neuroblastoma, with conditions including childhood metastatic pheoch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Pheochromocytoma

Drugs mentioned

• 131I-MIBG (metaiodobenzylguanidine)

Snippet

Sponsor: John Maris | Conditions: Neuroblastoma, Childhood Metastatic Pheochromocytoma | Status: AVAILABLE